146 related articles for article (PubMed ID: 10761993)
1. Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo.
Cucchi ML; Frattini P; Santagostino G; Orecchia G
Pigment Cell Res; 2000 Feb; 13(1):28-32. PubMed ID: 10761993
[TBL] [Abstract][Full Text] [Related]
2. Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report.
Orecchia G; Frattini P; Cucchi ML; Santagostino G
Dermatology; 1994; 189(4):350-3. PubMed ID: 7873818
[TBL] [Abstract][Full Text] [Related]
3. Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase.
Cucchi ML; Frattini P; Santagostino G; Preda S; Orecchia G
Pigment Cell Res; 2003 Apr; 16(2):111-6. PubMed ID: 12622787
[TBL] [Abstract][Full Text] [Related]
4. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
5. Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications.
Minegishi A; Ishizaki T; Yoshida Y; Ahagon A; Shibata N; Kobayashi H
Arch Neurol; 1987 Apr; 44(4):423-8. PubMed ID: 2435272
[TBL] [Abstract][Full Text] [Related]
6. Sources and significance of plasma levels of catechols and their metabolites in humans.
Goldstein DS; Eisenhofer G; Kopin IJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate.
Greene KA; Faull KF
J Neurochem; 1989 Oct; 53(4):1007-13. PubMed ID: 2769251
[TBL] [Abstract][Full Text] [Related]
8. Validation of an improved liquid chromatography tandem mass spectrometry method for rapid and simultaneous analysis of plasma catecholamine and their metabolites.
Yu S; Yin Y; Li Q; Yu J; Liu W; Wang D; Cheng Q; Xie S; Cheng X; Qiu L
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1129():121805. PubMed ID: 31670057
[TBL] [Abstract][Full Text] [Related]
9. New approaches to evaluate sympathoadrenal system activity in experiments on earth and in space.
Kvetnansky R; Noskov VB; Blazicek P; Macho L; Grigoriev AI; Goldstein DS; Kopin IJ
Acta Astronaut; 1994 Oct; 34():243-54. PubMed ID: 11540743
[TBL] [Abstract][Full Text] [Related]
10. Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome.
Garcia-Rudaz C; Armando I; Levin G; Escobar ME; Barontini M
Clin Endocrinol (Oxf); 1998 Aug; 49(2):221-8. PubMed ID: 9828911
[TBL] [Abstract][Full Text] [Related]
11. Detection of plasma and urinary monoamines and their metabolites in nonsegmental vitiligo.
Shahin Z; Leheta TM; Abdel Hay RM; Abdel Aal HM; Rashed LA
Acta Dermatovenerol Croat; 2012; 20(1):14-20. PubMed ID: 22507469
[TBL] [Abstract][Full Text] [Related]
12. [Significance of umbilical plasma concentrations of catecholamines and their metabolites in patients with term vaginal deliveries].
Ishizuka B; Hirata K; Matsumoto K; Ohno Y; Watanabe K; Kondoh T; Horikoshi H; Shiozaki K; Hamada H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):729-34. PubMed ID: 1890351
[TBL] [Abstract][Full Text] [Related]
13. Plasma catecholamines and their metabolites in obsessive-compulsive disorder.
Benkelfat C; Mefford IN; Masters CF; Nordahl TE; King AC; Cohen RM; Murphy DL
Psychiatry Res; 1991 Jun; 37(3):321-31. PubMed ID: 1891512
[TBL] [Abstract][Full Text] [Related]
14. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
Curtin F; Walker JP; Schulz P
J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
[TBL] [Abstract][Full Text] [Related]
15. Extraneuronal metabolism of endogenous and exogenous norepinephrine and epinephrine in rats.
Lenders JW; Kvetnansky R; Pacak K; Goldstein DS; Kopin IJ; Eisenhofer G
J Pharmacol Exp Ther; 1993 Jul; 266(1):288-93. PubMed ID: 8331563
[TBL] [Abstract][Full Text] [Related]
16. Catecholamines and vitiligo.
Morrone A; Picardo M; de Luca C; Terminali O; Passi S; Ippolito F
Pigment Cell Res; 1992 Mar; 5(2):65-9. PubMed ID: 1321419
[TBL] [Abstract][Full Text] [Related]
17. Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals.
Soda E; Miura I; Hoshino H; Kanno-Nozaki K; Ota T; Oguchi H; Watanabe K; Yang Q; Mashiko H; Niwa S
Psychiatry Res; 2014 Dec; 220(1-2):639-45. PubMed ID: 25200191
[TBL] [Abstract][Full Text] [Related]
18. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats.
Kvetnanský R; Fukuhara K; Pacák K; Cizza G; Goldstein DS; Kopin IJ
Endocrinology; 1993 Sep; 133(3):1411-9. PubMed ID: 8396019
[TBL] [Abstract][Full Text] [Related]
19. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.
Goldstein DS; Holmes C; Sharabi Y; Brentzel S; Eisenhofer G
Neurology; 2003 Apr; 60(8):1327-32. PubMed ID: 12707437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
